INNOVATIVE CLINICAL SOLUTIONS LTD (CIK: 0001002022) EDGAR, Information, Filings... CompaniesBIO.Com

INNOVATIVE CLINICAL SOLUTIONS LTD

Mailing address
10 DORRANCE STREET, SUITE 400, PROVIDENCE, Delaware, 02903
Phone
4018316755
State location
Rhode Island
State of incorporation
Delaware
Fiscal year end
January 31
SIC
8011 - (CF Office: Office of Life Sciences) SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Filings
N/A

INNOVATIVE CLINICAL SOLUTIONS LTD (CIK: 0001002022) is an American company incorporated in the state of Rhode Island. Head office is located at 10 DORRANCE ST, STE 400, PROVIDENCE, Rhode Island, 02903. Work in the industry 8011 - (CF Office: Office of Life Sciences) SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE. INNOVATIVE CLINICAL SOLUTIONS LTD is a public company and trade via Over-The-Counter (OTC).

Old names:

PHYMATRIX CORP from 1996-18-Jun to 1999-11-Jun

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by INNOVATIVE CLINICAL SOLUTIONS LTD

Filings	Format	Description	Filed/Effective	File/Film Number
15-15D	Document	Notice of suspension of duty to file reports pursuant to Section 13 and 15(d) of the Act Acc-no: 0000914260-03-000027 ( Act) Size: KB	Feb-14-2003	033-97854 03563569
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001132072-03-000023 ( Act) Size: KB	Feb-12-2003	005-46363 03553268
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001099281-03-000041 ( Act) Size: KB	Jan-31-2003	005-46363 03533241
8-K	Document	Current report filing Acc-no: 0000914260-03-000008 ( Act) Size: KB	Jan-21-2003	000-27568 03519802
8-K	Document	Current report filing Acc-no: 0000914260-02-000065 ( Act) Size: KB	Sep-23-2002	000-27568 02770104
8-K/A	Document	Amendment to Current report filing Acc-no: 0000914260-02-000060 ( Act) Size: KB	Aug-15-2002	000-27568 02739550
8-K	Document	Current report filing Acc-no: 0000914260-02-000058 ( Act) Size: KB	Aug-07-2002	000-27568 02721389
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000912057-02-023837 ( Act) Size: KB	Jun-11-2002	005-46363 02676719
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0000912057-02-023293 ( Act) Size: KB	Jun-06-2002	000-27568 02672322
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001099281-02-000144 ( Act) Size: KB	Jun-05-2002	005-46363 02671212
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0000914260-02-000041 ( Act) Size: KB	May-01-2002	000-27568 02630126
8-K	Document	Current report filing Acc-no: 0000914260-02-000037 ( Act) Size: KB	Mar-22-2002	000-27568 02582055
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001132072-02-000056 ( Act) Size: KB	Feb-27-2002	005-46363 02560744
8-K	Document	Current report filing Acc-no: 0000914260-02-000027 ( Act) Size: KB	Feb-20-2002	000-27568 02554475
8-K	Document	Current report filing Acc-no: 0000914260-02-000009 ( Act) Size: KB	Jan-28-2002	000-27568 02518523
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001099281-02-000010 ( Act) Size: KB	Jan-10-2002	005-46363 2505769
DEFA14C	Document	Definitive additional information statement materials including Rule 14(a)(12) material Acc-no: 0000912057-02-000825 ( Act) Size: KB	Jan-09-2002	000-27568 2505258
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000912057-01-544469 ( Act) Size: KB	Dec-21-2001	000-27568 1822003
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0000914260-01-500027 ( Act) Size: KB	Dec-17-2001	000-27568 1815553
DEF 14C	Document	Definitive information statements Acc-no: 0000912057-01-542731 ( Act) Size: KB	Dec-11-2001	000-27568 1811043

Recent 20 filings. View all INNOVATIVE CLINICAL SOLUTIONS LTD filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

INNOVATIVE CLINICAL SOLUTIONS LTD overview
INNOVATIVE CLINICAL SOLUTIONS LTD job
INNOVATIVE CLINICAL SOLUTIONS LTD stock
INNOVATIVE CLINICAL SOLUTIONS LTD ownership
INNOVATIVE CLINICAL SOLUTIONS LTD CEO
INNOVATIVE CLINICAL SOLUTIONS LTD documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.